Farmácia/Notícias da Indústria

Diretrizes atualizadas da IDSA sobre tratamento e manejo de pacientes com COVID-19.

16 Mai, 2022 | 16:44h

IDSA Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America

Revisão liderada por farmacêuticos pode melhorar as prescrições de antibióticos na alta hospitalar.

16 Mai, 2022 | 16:25h

Comentário: Pharmacist-led review tied to better antimicrobial prescribing at discharge – CIDRAP

Estudo original: Pharmacist-Driven Transitions of Care Practice Model for Prescribing Oral Antimicrobials at Hospital Discharge – JAMA Network Open

Estudo randomizado | Avaliação da vacina de mRNA-1273 contra Covid-19 em crianças de 6 a 11 anos de idade.

13 Mai, 2022 | 12:55h

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age – New England Journal of Medicine

Comentário no Twitter

Two 50-μg doses of mRNA-1273 vaccine were found to be safe and effective in inducing immune responses and preventing Covid-19 in children 6 to 11 years of age. https://t.co/A5SBK4zK6E pic.twitter.com/7x4JgOwK57

— NEJM (@NEJM) May 11, 2022

Revisão sistemática | Prevalência de transtorno do uso de opioides entre pacientes com dor relacionada a câncer.

12 Mai, 2022 | 14:52h

Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review – Journal of Clinical Medicine

M-A | Intervenções para melhorar a cobertura de imunização entre crianças e adolescentes.

12 Mai, 2022 | 14:49h

Interventions to Improve Immunization Coverage Among Children and Adolescents: A Meta-analysis – Pediatrics

Diretriz pública ECRI e ISMP | Erros médicos são complexos; acusações criminais não melhorarão o cuidado.

12 Mai, 2022 | 14:45h

ECRI and ISMP PUBLIC STATEMENT | Medication Errors are Complex; Criminal Charges Will Not Improve Care – Institute for Safe Medication Practices

Ver também:

ISMP Speaks Out Against Criminalization of Medication Errors – Institute for Safe Medication Practices

The simple thing hospitals can do to prevent dangerous drug mistakes – CNN

Revisão | Primeira geração de antivirais orais contra SARS-CoV-2.

12 Mai, 2022 | 14:43h

First-generation Oral Antivirals Against SARS-CoV-2 – Clinical Microbiology and Infection

Revisão | Avaliação e tratamento da função cognitiva de pacientes com câncer de próstata tratados com inibidores do receptor androgênico de segunda geração.

12 Mai, 2022 | 14:18h

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors – CNS Drugs

Estudos mostram 2 novas plataformas promissoras de vacina contra COVID-19.

10 Mai, 2022 | 14:28h

Comentário: Studies show promise for 2 new COVID vaccine platforms – CIDRAP

Estudo 1: Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine – New England Journal of Medicine

Estudo 2: Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults – New England Journal of Medicine

Editorial: Does the World Still Need New Covid-19 Vaccines?

Comentários no Twitter

Efficacy of a plant-based vaccine with adjuvant was 69.5% against symptomatic #COVID19 and 78.8% against moderate-to-severe disease. https://t.co/WH54QWCBdg pic.twitter.com/BiEYpJUD7D

— NEJM (@NEJM) May 4, 2022

ZF2001 vaccine has 87% efficacy against critical or severe #COVID19 for at least 6 months after full vaccination and was safe in large cohort of adults. #IDTwitter https://t.co/wsG0AXqI4Y pic.twitter.com/45fqwVrz9a

— NEJM (@NEJM) May 4, 2022

Revisão sistemática | Cannabis e canabinoides para tratamento sintomático de pessoas com esclerose múltipla.

10 Mai, 2022 | 12:27h

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis – Cochrane Library

Resumo: Cannabis and cannabinoids for people with multiple sclerosis – Cochrane Library